All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Coinbase CEO Brian Armstrong's Biotech Startup Newlimit Raises $435M, Valuation Triples to $3.1B

By

Shiraz Jagati

2h ago· 3 min readenNews

Summary

Newlimit, the longevity biotech co-founded by Coinbase CEO Brian Armstrong, raised $435 million in a Series C round led by Founders Fund, tripling its valuation to approximately $3.1 billion. The funding round marks a significant influx of crypto wealth into longevity science and anti-aging research.

Key quotes

· 3 pulled
Newlimit, the anti-aging biotech co-founded by Coinbase Global Inc. (Nasdaq: COIN) Chief Executive Brian Armstrong, has closed a $435 million Series C funding round.
The raise was led by Founders Fund and roughly tripled Newlimit's post-money valuation to about $3.1 billion, up from a mark that sat below $1 billion.
Crypto Wealth Flows Into Longevity Science
Snippet from the RSS feed
NewLimit, co-founded by Coinbase CEO Brian Armstrong, raised a $435 million Series C led by Founders Fund, tripling its valuation to $3.1 billion.

You might also wanna read